Let’s do something
about fibromyalgia pain.

See if the RESILIENT Study is right for you.

The RESILIENT Study for Fibromyalgia - Now Enrolling


Over 5 million Americans are affected by fibromyalgia - a complex and often misunderstood chronic pain condition. Symptoms of fibromyalgia can vary depending on the person, weather, or even time of day. Some of the more common symptoms include:

  • Chronic, widespread pain throughout the body or in multiple locations
  • Pain that feels aching, burning, or throbbing
  • Fatigue or an overwhelming feeling of being tired
  • Trouble sleeping

The exact cause of fibromyalgia is unknown, but studies show that sufferers have a heightened sensitivity to pain. And although there is no cure for fibromyalgia, doctors and researchers are studying new ways to potentially reduce symptoms and improve quality of life.

Right now, doctors at 30 locations across the US are conducting a new phase 3 clinical trial for fibromyalgia, called the RESILIENT Study. The study is for an investigational drug that may help improve fibromyalgia symptoms and sleep quality when taken nightly at bedtime for 14 weeks.

Participants in the RESILIENT Study will receive all study-related care at no cost. You will also be compensated for your time and travel to attend periodic visits at your local study doctor’s office to monitor your progress (up to 6 visits over a 4 month period).

Frequent Questions


Clinical studies or trials are used to learn about the safety and effectiveness of new medications, medical devices, medical procedures, or other types of intervention. Although there are many types of clinical trials, all must conform to strict rules set by the U.S. Food and Drug Administration (FDA). These rules help protect the rights and safety of those who volunteer to take part in clinical trials.

It is expected that 470 people will participate in the RESILIENT Study at approximately 30 locations across the U.S.
Yes, the study drug (called TNX-102 SL) has been used in multiple previous clinical studies for fibromyalgia pain. The RESILIENT Study is a phase 3 study.
If you qualify and choose to join the RESILIENT Study, you will receive study-related care at no cost to you. This includes the study drug, as well as any visits to your study doctor’s office. Health insurance is not required to participate.
If you join the study, your participation will last about 4 months. During this time, you will be asked to meet with your local study doctor up to 6 times to provide feedback about your experiences. You will be compensated for your time and travel to attend these visits.

As with all clinical studies, your participation is completely voluntary. You may leave the study at any time without any effect on your future medical care.

To see if you might qualify for the RESILIENT Study, and to get connected with your local study center, the next step is taking the pre-screening questionnaire. Please scroll down to get started.

See If You Qualify


If you suffer from fibromyalgia and are 18 - 65 years old, you may be eligible to participate in the RESILIENT Study. To see if you might qualify, and to connect with a local study center to learn more, please take the questionnaire below.